Y0405565 | 盐酸纳洛酮注射液 | naloxone hydrochloride | Injection | Chemical Drugs(6) | Generic Drug | 2004-07-29 | 北京凯因生物技术有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2005-02-21 | view |
Y0405564 | 盐酸纳洛酮注射液 | naloxone hydrochloride | Injection | Chemical Drugs(6) | Generic Drug | 2004-07-29 | 北京凯因生物技术有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2005-02-21 | view |
Y0403238 | 注射用奥扎格雷钠 | ozagrel sodium | Lyophilized | Chemical Drugs(6) | Generic Drug | 2004-05-17 | 北京凯因生物技术有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2004-12-31 | view |
Y0403231 | 注射用更昔洛韦 | ganciclovir | Lyophilized | Chemical Drugs(6) | Generic Drug | 2004-10-12 | 北京凯因生物技术有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2005-01-28 | view |
Y0403230 | 注射用更昔洛韦 | ganciclovir | Lyophilized | Chemical Drugs(6) | Generic Drug | 2004-10-12 | 北京凯因生物技术有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2005-01-28 | view |
Y0400019 | 注射用盐酸吡硫醇 | pyritinol hydrochloride | Lyophilized | Chemical Drugs(6) | Generic Drug | 2004-01-08 | 北京凯因生物技术有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2004-08-09 | view |
X0406708 | 重组人干扰素α2b阴道泡腾片 | Recombinant Human Interferon α2b | Tablet | Biological Products(13) | New Drug Application | 2004-11-17 | 北京凯因生物技术有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2005-07-08 | view |
X0302500 | 重组人干扰素α2b滴眼液 | Recombinant Human Interferon α2b | Eye drops | Biological Products(14) | New Drug Application | 2004-01-15 | 北京凯因生物技术有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2004-07-29 | view |
X0302499 | 重组人干扰素α2b喷雾剂 | Recombinant Human Interferon α2b | Spray | Biological Products(14) | New Drug Application | 2003-05-28 | 北京凯因生物技术有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2006-09-13 | view |
X0302498 | 重组人干扰素α2b喷雾剂 | Recombinant Human Interferon α2b | Spray | Biological Products(14) | New Drug Application | 2003-05-28 | 北京凯因生物技术有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2006-09-13 | view |
JXHL1400058 | 甘油磷酰胆碱口服液 | choline alfoscerate | Oral solution | Chemical Drugs | Import Drug Application | 2014-03-05 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2016-01-15 | view |
CYSB2400273 | 人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2024-10-15 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
CYSB2400272 | 人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2024-10-15 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
CYSB2400271 | 人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2024-10-15 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
CYSB2200225 | 培集成干扰素α-2注射液 | peginterferon alfacon-2 | Injection | Biological Products | Supplementary Application | 2022-09-09 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
CYSB2200184 | 人干扰素α2b阴道泡腾片 | Recombinant Human Interferon α2b | Tablet | Biological Products | Supplementary Application | 2022-07-28 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
CYSB1800231 | 重组人干扰素α2b阴道泡腾片 | Recombinant Human Interferon α2b | Tablet | Biological Products | Supplementary Application | 2018-10-29 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2020-11-03 | view |
CYSB1800230 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2018-10-29 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2020-10-27 | view |
CYSB1800229 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2018-10-29 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2020-10-27 | view |
CYSB1800228 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2018-10-29 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2020-10-27 | view |